| The albumin-binding domain as a scaffold for protein engineering J Nilvebrant, S Hober Computational and structural biotechnology journal 6 (7), e201303009, 2013 | 141 | 2013 |
| Pneumolysin binds to the mannose receptor C type 1 (MRC-1) leading to anti-inflammatory responses and enhanced pneumococcal survival K Subramanian, DR Neill, HA Malak, L Spelmink, S Khandaker, ... Nature microbiology 4 (1), 62-70, 2019 | 119 | 2019 |
| ADAPT, a novel scaffold protein-based probe for radionuclide imaging of molecular targets that are expressed in disseminated cancers J Garousi, S Lindbo, J Nilvebrant, M Åstrand, J Buijs, M Sandström, ... Cancer research 75 (20), 4364-4371, 2015 | 83 | 2015 |
| Engineering of bispecific affinity proteins with high affinity for ERBB2 and adaptable binding to albumin J Nilvebrant, M Åstrand, M Georgieva-Kotseva, M Björnmalm, J Löfblom, ... PloS one 9 (8), e103094, 2014 | 77 | 2014 |
| Progress and future directions with peptide-drug conjugates for targeted cancer therapy J Lindberg, J Nilvebrant, PÅ Nygren, F Lehmann Molecules 26 (19), 6042, 2021 | 65 | 2021 |
| Engineering bispecificity into a single albumin-binding domain J Nilvebrant, T Alm, S Hober, J Löfblom PLoS One 6 (10), e25791, 2011 | 60 | 2011 |
| Cotargeting ephrin receptor tyrosine kinases A2 and A3 in cancer stem cells reduces growth of recurrent glioblastoma MA Qazi, P Vora, C Venugopal, J Adams, M Singh, A Hu, M Gorelik, ... Cancer Research 78 (17), 5023-5037, 2018 | 57 | 2018 |
| An introduction to epitope mapping J Nilvebrant, J Rockberg Epitope Mapping Protocols, 1-10, 2018 | 53 | 2018 |
| A small bispecific protein selected for orthogonal affinity purification T Alm, L Yderland, J Nilvebrant, A Halldin, S Hober Biotechnology Journal 5 (6), 605-617, 2010 | 50 | 2010 |
| Development and characterization of small bispecific albumin-binding domains with high affinity for ErbB3 J Nilvebrant, M Åstrand, J Löfblom, S Hober Cellular and molecular life sciences 70, 3973-3985, 2013 | 46 | 2013 |
| Successive crystal structure snapshots suggest the basis for MHC class I peptide loading and editing by tapasin I Hafstrand, EC Sayitoglu, A Apavaloaei, BJ Josey, R Sun, X Han, ... Proceedings of the National Academy of Sciences 116 (11), 5055-5060, 2019 | 45 | 2019 |
| Protein engineering allows for mild affinity-based elution of therapeutic antibodies S Kanje, R Venskutonytė, J Scheffel, J Nilvebrant, K Lindkvist-Petersson, ... Journal of molecular biology 430 (18), 3427-3438, 2018 | 40 | 2018 |
| Engineered autonomous human variable domains J Nilvebrant, P M. Tessier, S S. Sidhu Current pharmaceutical design 22 (43), 6527-6537, 2016 | 37 | 2016 |
| Selection and in vitro characterization of human CD44v6‐binding antibody fragments J Nilvebrant, G Kuku, H Björkelund, M Nestor Biotechnology and applied biochemistry 59 (5), 367-380, 2012 | 37 | 2012 |
| Bispecific applications of non-immunoglobulin scaffold binders S Hober, S Lindbo, J Nilvebrant Methods 154, 143-152, 2019 | 31 | 2019 |
| CD44v6‐Targeted Imaging of Head and Neck Squamous Cell Carcinoma: Antibody‐Based Approaches D Spiegelberg, J Nilvebrant Contrast media & molecular imaging 2017 (1), 2709547, 2017 | 31 | 2017 |
| Construction of synthetic antibody phage-display libraries J Nilvebrant, SS Sidhu Phage Display: Methods and Protocols, 45-60, 2018 | 29 | 2018 |
| In vivo characterization of the novel CD44v6-targeting Fab fragment AbD15179 for molecular imaging of squamous cell carcinoma: a dual-isotope study AK Haylock, D Spiegelberg, J Nilvebrant, K Sandström, M Nestor EJNMMI research 4, 1-13, 2014 | 22 | 2014 |
| Engineering of Protein A for improved purification of antibodies and Fc-fused proteins S Kanje, J Scheffel, J Nilvebrant, S Hober Approaches to the Purification, Analysis and Characterization of Antibody …, 2020 | 21 | 2020 |
| Purification systems based of bacterial surface proteins T Boström, J Nilvebrant, S Hober InTech 1, 89-136, 2012 | 21 | 2012 |
